| Efficacy of tocilizumab in patients hospitalized with Covid-19 JH Stone, MJ Frigault, NJ Serling-Boyd, AD Fernandes, L Harvey, ... New England Journal of Medicine 383 (24), 2333-2344, 2020 | 1561 | 2020 |
| Transmission of SARS-CoV-2: a review of viral, host, and environmental factors EA Meyerowitz, A Richterman, RT Gandhi, PE Sax Annals of internal medicine 174 (1), 69-79, 2021 | 1079 | 2021 |
| Liver biochemistries in hospitalized patients with COVID‐19 PP Bloom, EA Meyerowitz, Z Reinus, M Daidone, J Gustafson, AY Kim, ... Hepatology 73 (3), 890-900, 2021 | 250 | 2021 |
| Towards an accurate and systematic characterisation of persistently asymptomatic infection with SARS-CoV-2 EA Meyerowitz, A Richterman, II Bogoch, N Low, M Cevik The Lancet infectious diseases 21 (6), e163-e169, 2021 | 206 | 2021 |
| Rethinking the role of hydroxychloroquine in the treatment of COVID‐19 EA Meyerowitz, AGL Vannier, MGN Friesen, S Schoenfeld, JA Gelfand, ... The FASEB Journal 34 (5), 6027-6037, 2020 | 184 | 2020 |
| Hospital-acquired SARS-CoV-2 infection: lessons for public health A Richterman, EA Meyerowitz, M Cevik Jama 324 (21), 2155-2156, 2020 | 150 | 2020 |
| Human monkeypox virus infection in women and non-binary individuals during the 2022 outbreaks: a global case series JP Thornhill, R Palich, J Ghosn, S Walmsley, D Moschese, CP Cortes, ... The Lancet 400 (10367), 1953-1965, 2022 | 147 | 2022 |
| Disproportionate burden of coronavirus disease 2019 among racial minorities and those in congregate settings among a large cohort of people with HIV EA Meyerowitz, AY Kim, KL Ard, N Basgoz, JT Chu, RM Hurtado, CK Lee, ... Aids 34 (12), 1781-1787, 2020 | 105 | 2020 |
| Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: update of a living systematic review and meta-analysis D Buitrago-Garcia, AM Ipekci, L Heron, H Imeri, L Araujo-Chaveron, ... PLoS medicine 19 (5), e1003987, 2022 | 79 | 2022 |
| Indirect protection by reducing transmission: ending the pandemic with severe acute respiratory syndrome coronavirus 2 vaccination A Richterman, EA Meyerowitz, M Cevik Open Forum Infectious Diseases 9 (2), ofab259, 2022 | 64 | 2022 |
| Early clinical and sociodemographic experience with patients hospitalized with COVID-19 at a large American healthcare system CP McCarthy, S Murphy, M Jones-O'Connor, DS Olshan, JR Khambhati, ... EClinicalMedicine 26, 2020 | 60 | 2020 |
| Immunomodulation as treatment for severe coronavirus disease 2019: a systematic review of current modalities and future directions EA Meyerowitz, P Sen, SR Schoenfeld, TG Neilan, MJ Frigault, JH Stone, ... Clinical Infectious Diseases 72 (12), e1130-e1143, 2021 | 44 | 2021 |
| Clinical course and management of COVID-19 in the era of widespread population immunity EA Meyerowitz, J Scott, A Richterman, V Male, M Cevik Nature Reviews Microbiology 22 (2), 75-88, 2024 | 38 | 2024 |
| SARS-CoV-2 transmission and prevention in the era of the Delta variant EA Meyerowitz, A Richterman Infectious disease clinics of North America 36 (2), 267, 2022 | 26 | 2022 |
| Clinical and demographic factors associated with COVID-19, severe COVID-19, and SARS-CoV-2 infection in adults: a secondary cross-protocol analysis of 4 randomized clinical trials DA Theodore, AR Branche, L Zhang, DS Graciaa, M Choudhary, ... JAMA network open 6 (7), e2323349-e2323349, 2023 | 20 | 2023 |
| Isolated cerebral mucormycosis in immunocompetent adults who inject drugs: case reports and systematic review of the literature EA Meyerowitz, S Sanchez, MK Mansour, VA Triant, MB Goldberg Open Forum Infectious Diseases 7 (12), ofaa552, 2020 | 20 | 2020 |
| Anorectal testing for Monkeypox virus infection in men who have sex with men with and without proctitis EA Meyerowitz, I Gendlina, VJ Desai, R Grossberg, SR Nair, B Pujar, ... Clin Infect Dis 8, 24-27, 2022 | 13 | 2022 |
| Transmission of SARS-CoV-2 EA Meyerowitz, A Richterman, RT Gandhi, PE Sax Annals of Internal Medicine 174 (7), 1037, 2021 | 12 | 2021 |
| Probing the conformation and dynamics of allatostatin neuropeptides: A structural model for functional differences M Banerjee, E Meyerowitz, C Huang, S Mohanty Peptides 29 (3), 375-385, 2008 | 10 | 2008 |
| the landscape of antiviral therapy for COVID-19 in the era of widespread population immunity and Omicron-lineage viruses EA Meyerowitz, Y Li Clinical Infectious Diseases 78 (4), 908-917, 2024 | 9 | 2024 |